Table 2. Summary of patient characteristics ( n = 127) .
| Variable | N (%) |
|---|---|
| Sex | |
| Male | 68 (53.5%) |
| Female | 59 (46.5%) |
| Insurance (primary) | |
| Commercial | 52 (40.9%) |
| Noncommercial | 75 (59.1%) |
| Age group | |
| 0–5 mo | 5 (3.9%) |
| 6 mo–11 y | 51 (40.2%) |
| 12–17 y | 27 (21.3%) |
| 18 < 26 y | 44 (34.7%) |
| Race | |
| White | 80 (63%) |
| Not white | 47 (37%) |
| Ethnicity | |
| Non-Hispanic | 85 (66.9%) |
| Hispanic or other | 42 (33.1%) |
| Location | |
| Inpatient | 92 (72.4%) |
| Outpatient | 35 (27.6%) |
| Provider location | |
| Pediatric | 98 (77.2%) |
| Adult | 29 (22.8%) |
| Chemo type | |
| Cisplatin | 34 (26.8%) |
| Noncisplatin | 93 (73.2%) |
| Cancer type | |
| Solid tumor | 62 (48.8%) |
| Lymphoma | 38 (29.9%) |
| Central nervous system | 15 (11.8%) |
| Leukemia | 12 (9.5%) |
| Cancer status | |
| First occurrence | 115 (90.6%) |
| Relapse | 12 (9.4%) |